Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scholar Rock Holding Corp

33.12
+0.35001.07%
Volume:455.21K
Turnover:14.90M
Market Cap:3.14B
PE:-12.62
High:33.37
Open:32.00
Low:31.98
Close:32.77
Loading ...

Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Compass Therapeutics (CMPX)

TIPRANKS
·
29 Apr

Scholar Rock Switches Up Executive Suite

Dow Jones
·
28 Apr

Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth

THOMSON REUTERS
·
28 Apr

Scholar Rock Holding Corp - Vikas Sinha Appointed as CFO

THOMSON REUTERS
·
28 Apr

Piper Sandler Remains a Buy on Scholar Rock Holding (SRRK)

TIPRANKS
·
23 Apr

Scholar Rock Holding Corp (SRRK) Q4 2024 Earnings Call Highlights: Clinical Success and ...

GuruFocus.com
·
22 Apr

Scholar Rock Application for Spinal Muscular Atrophy Treatment Gets FDA Approval

Dow Jones
·
25 Mar

BUZZ-Scholar Rock gains as muscle disorder drug gets priority US review

Reuters
·
25 Mar

BRIEF-FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy

Reuters
·
25 Mar

BRIEF-Scholar Rock appoints Erin Moore as interim Principal Financial Officer

Reuters
·
22 Mar

Scholar Rock Holding Corp: Appoints Erin Moore as Interim Principal Financial Officer & Interim Principal Accounting Officer, Effective March 21, 2025

THOMSON REUTERS
·
22 Mar

TD Cowen Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)

TIPRANKS
·
17 Mar

Truist Financial Remains a Buy on Scholar Rock Holding (SRRK)

TIPRANKS
·
17 Mar

Scholar Rock Study of Potential Spinal Muscular Atrophy Treatment Meets Secondary Endpoints

MT Newswires Live
·
17 Mar

Scholar Rock announces Phase 3 SAPPHIRE data

TIPRANKS
·
17 Mar

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Business Wire
·
17 Mar

When Can We Expect A Profit From Scholar Rock Holding Corporation (NASDAQ:SRRK)?

Simply Wall St.
·
06 Mar

Stock Track | Scholar Rock's SMA Drug Apitegromab Fuels 5.06% Surge on Promising Trial Results and Commercial Readiness

Stock Track
·
01 Mar

Q4 2024 Scholar Rock Holding Corp Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Wedbush Adjusts Scholar Rock Price Target to $50 From $47, Maintains Outperform Rating

MT Newswires Live
·
28 Feb